Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 306-314, June 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sibley, J. A.
Right arrow Articles by Higgins, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sibley, J. A.
Right arrow Articles by Higgins, G. M.

Significance of the Level of Serum Aldolase in Tumor-bearing Animals*

John A. Sibley, Gerard A. Fleisher and George M. Higgins

( Mayo Clinic and Mayo Foundation, {dagger} Rochester, Minnesota)

In this investigation of the significance of elevated levels of serum aldolase in rats bearing the Walker carcinosarcoma 256 it was found that the enzyme content in the blood leaving the tumor was higher than in heart blood. Surgical removal of the tumor caused the level of serum aldolase to fall promptly to the normal range, the rate of fall paralleling the rate of disappearance of crystalline aldolase injected intravenously. Anemia, cachexia, and the presence of the spleen or the adrenal glands were unrelated to the level of the serum enzyme. X-ray treatment of the tumor, or the administration of urethan, aminopterin, or nitrogen mustard, usually caused a fall in the elevated level of the enzyme.

In experiments with tissue slices, aldolase was released from tumor tissue into the medium under anaerobic conditions, particularly when glucose was not added to the medium. In the presence of oxygen and glucose, aldolase was retained in the cells.

Bilateral nephrectomy or bilateral ligation of the ureters caused an increase of serum aldolase in normal rats; these procedure delayed but did not prevent the disappearance of intravenously injected crystalline aldolase. Ligation of the bile duct did not produce an increased amount of aldolase in the blood serum.

The evidence provided by the data assembled indicates that the elevated levels of serum aldolase result from its increased liberation from the tumor, at a rate exceeding its elimination from the circulation. It is suggested that this increased liberation derives from foci of necrosis in the tumor and that it is not a characteristic of malignant tissue per se.

* Abridgment of thesis submitted by Dr. Sibley to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements of the degree of Doctor of Philosophy in Urology.

{dagger} The Mayo Foundation, Rochester, Minnesota, is a part of the Graduate School of the University of Minnesota.

Received 1/18/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.